Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free ONPH Stock Alerts

Oncology Pharma (ONPH) Short Interest Ratio & Short Volume

Oncology Pharma logo
$0.07 +0.00 (+0.29%)
As of 03:38 PM Eastern
Compare

Oncology Pharma Short Interest Overview

As of April 15, 2026, Oncology Pharma (ONPH) had a short interest of 13,438 shares sold short, representing 0.04% of the public float. This marks a 0.00% change in short interest since the prior report. The short interest ratio (days to cover) is 0.2, meaning it would take 0.2 days of the average trading volume of 38,390 shares to cover all short positions.

Current Short Interest
13,438 shares
Previous Short Interest
13,438 shares
Change Vs. Previous Month
0.00%
Dollar Volume Sold Short
$1.46 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
38,660,000 shares
Short Percent of Float
0.04%
Today's Trading Volume
47,623 shares
Average Trading Volume
38,390 shares
Today's Volume Vs. Average
124%
Short Selling Oncology Pharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Oncology Pharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ONPH Short Interest Over Time

ONPH Days to Cover Over Time

ONPH Percentage of Float Shorted Over Time

Oncology Pharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202613,438 shares $1.46 thousand No Change0.0%0.18 $0.11
3/31/202613,438 shares $1.09 thousand No Change0.0%0.04 $0.08
3/13/202613,438 shares $147.82 No Change0.0%0.44 $0.01
2/27/202613,438 shares $107.50 No Change0.0%3.21 $0.01
2/13/202613,438 shares $53.75 No Change0.0%4 $0.00
1/30/202613,438 shares $53.75 -0.1%0.0%3.76 $0.00
1/15/202613,451 shares $53.80 No Change0.0%2.22 $0.00
12/31/202513,451 shares $53.80 No Change0.0%0.44 $0.00
12/15/202513,451 shares $53.80 No Change0.0%1.14 $0.00
11/28/202513,451 shares $53.80 No Change0.0%2.6 $0.00
11/14/202513,451 shares $1.35 No Change0.0%0.43 $0.00
10/31/202513,451 shares $2.69 No Change0.0%0.88 $0.00
10/15/202513,500 shares $9.45 No Change0.0%0.7 $0.00
9/30/202513,500 shares $6.75 No ChangeN/A0.9 $0.00
9/15/202513,500 shares $0.00 No ChangeN/A6.4 $0.00
8/31/202513,500 shares $2.70 No Change0.0%1.9 $0.00
8/15/202513,500 shares $2.70 No ChangeN/A5 $0.00
7/31/202513,500 shares $0.00 No Change0.0%19.3 $0.00
7/15/202513,500 shares $1.35 No ChangeN/A3.2 $0.00
6/30/202513,500 shares $0.00 No Change0.0%6.8 $0.00
6/15/202513,500 shares $1.35 No Change0.0%6.4 $0.00
5/31/202513,500 shares $1.35 No ChangeN/A3.2 $0.00
5/15/202513,500 shares $1.35 No ChangeN/A4 $0.00
4/30/202513,500 shares $1.35 No ChangeN/A3.6 $0.00
4/15/202513,500 shares $1.35 No ChangeN/A0.5 $0.00
3/31/202513,500 shares $0.00 No ChangeN/A2 $0.00
3/15/202513,500 shares $1.35 No ChangeN/A0.6 $0.00
2/28/202513,500 shares $0.00 No ChangeN/A2.5 $0.00
2/15/202513,500 shares $0.00 No ChangeN/A22.5 $0.00
1/31/202513,500 shares $0.00 No ChangeN/A3.6 $0.00
1/15/202513,500 shares $1.35 No ChangeN/A3.1 $0.00
12/31/202413,500 shares $1.35 No ChangeN/A0.3 $0.00
12/15/202413,500 shares $2.70 No ChangeN/A0.5 $0.00
11/30/202413,500 shares $0.00 No ChangeN/A0.6 $0.00
11/15/202413,500 shares $0.00 No ChangeN/A1.6 $0.00
10/31/202413,500 shares $0.00 No ChangeN/A4.1 $0.00
10/15/202413,500 shares $1.35 No ChangeN/A3.8 $0.00
9/30/202413,500 shares $0.00 No ChangeN/A1.1 $0.00
9/15/202413,500 shares $0.00 No ChangeN/A0.4 $0.00
8/31/202413,500 shares $0.00 No ChangeN/A0.5 $0.00
8/15/202413,500 shares $2.70 No ChangeN/A4.7 $0.00
7/31/202413,500 shares $2.70 No ChangeN/A9.6 $0.00
7/15/202413,500 shares $0.00 No ChangeN/A1.2 $0.00
6/30/202413,500 shares $0.00 No ChangeN/A4.8 $0.00
6/15/202413,500 shares $0.00 No ChangeN/A4.8 $0.00
5/31/202413,500 shares $0.00 -3.6%N/A2.7 $0.00
5/15/202414,000 shares $0.00 +3.7%N/A6.1 $0.00
4/30/202413,500 shares $0.00 No ChangeN/A1.5 $0.00
4/15/202413,500 shares $135.00 No ChangeN/A1.2 $0.01
3/31/202413,500 shares $1.35 No ChangeN/A4.5 $0.00
3/15/202413,500 shares $0.00 -0.7%N/A1.7 $0.00
2/29/202413,600 shares $0.00 No ChangeN/A2.4 $0.00
2/15/202413,600 shares $0.00 No ChangeN/A2.7 $0.00
1/15/202413,600 shares $0.00 No ChangeN/A3 $0.00
12/31/202313,600 shares $2.72 -4.9%N/A0.1 $0.00
12/15/202314,300 shares $2.86 -10.1%N/A0.3 $0.00
11/30/202315,900 shares $15.90 -52.0%N/A1 $0.00
11/15/202333,100 shares $33.10 -32.2%N/A2.7 $0.00
10/31/202348,800 shares $976.00 -17.2%N/A10 $0.02
10/15/202358,900 shares $2.21 thousand -35.5%N/A6.5 $0.04
9/30/202391,300 shares $5.93 thousand -1.0%N/A13.8 $0.07
9/15/202392,200 shares $4.38 thousand -1.4%N/A10.5 $0.05
8/31/202393,500 shares $2.34 thousand +523.3%N/A4.3 $0.03
8/15/202315,000 shares $4.28 thousand -6.8%N/A0.2 $0.29
7/31/202316,100 shares $5.73 thousand +16.7%N/A0.3 $0.36
7/15/202313,800 shares $5.42 thousand -21.1%N/A0.3 $0.39
6/30/202317,500 shares $5.60 thousand +19.9%N/A0.1 $0.32
6/15/202314,600 shares $8.18 thousand -3.3%N/A0 $0.56
5/31/202315,100 shares $2.11 thousand -22.6%N/A0.1 $0.14
5/15/202319,500 shares $2.73 thousand +20.4%N/A0.1 $0.14
4/30/202316,200 shares $2.59 thousand -30.5%N/A0.1 $0.16
4/15/202323,300 shares $3.90 thousand -14.7%N/A0.2 $0.17
3/31/202327,300 shares $5.05 thousand +45.2%N/A0.1 $0.19
3/15/202318,800 shares $5.45 thousand -25.1%N/A0.2 $0.29
2/28/202325,100 shares $9.09 thousand +9.6%N/A0.4 $0.36
2/15/202322,900 shares $8.70 thousand -24.7%N/A0.2 $0.38
1/31/202330,400 shares $11.70 thousand +28.8%N/A0.3 $0.39
1/15/202323,600 shares $9.68 thousand -32.2%N/A0.1 $0.41
12/30/202234,800 shares $11.78 thousand +5.1%N/A0.1 $0.34
12/15/202233,100 shares $16.88 thousand -3.2%N/A0.2 $0.51
11/30/202234,200 shares $24.54 thousand -6.8%N/A0.6 $0.72
11/15/202236,700 shares $34.13 thousand -35.8%N/A0.2 $0.93
10/31/202257,200 shares $50.85 thousand -5.9%N/A0.5 $0.89
10/15/202260,800 shares $26.14 thousand -60.2%N/A0.4 $0.43
9/30/2022152,700 shares $70.24 thousand +2.9%N/A1 $0.46
9/15/2022148,400 shares $129.09 thousand +1.0%N/A2.5 $0.87
8/31/2022146,900 shares $149.84 thousand -0.2%N/A1.6 $1.02
8/15/2022147,200 shares $198.72 thousand -14.6%N/A1.3 $1.35
7/31/2022172,400 shares $231.02 thousand -6.7%N/A1.1 $1.34
7/15/2022184,700 shares $265.97 thousand -33.3%N/A1.2 $1.44
6/30/2022276,800 shares $405.79 thousand -4.2%N/A3.7 $1.47
6/15/2022288,900 shares $433.35 thousand -28.2%N/A1.8 $1.50
5/31/2022402,600 shares $805.20 thousand -3.3%N/A4.3 $2.00
5/15/2022416,300 shares $865.28 thousand -3.8%N/A2.8 $2.08
4/30/2022432,500 shares $1.28 million -1.0%N/A4.2 $2.96
4/15/2022437,000 shares $1.56 million +1.8%N/A4.2 $3.57
3/31/2022429,400 shares $1.59 million -16.6%N/A3 $3.70
3/15/2022515,000 shares $2.11 million -4.8%N/A1.6 $4.10
2/28/2022541,000 shares $2.75 million -4.0%N/A1 $5.08
2/15/2022563,400 shares $3.61 million +41.1%N/A1.2 $6.41
1/31/2022399,400 shares $1.34 million +4.0%N/A3.4 $3.36
1/15/2022384,100 shares $1.43 million -9.3%N/A1.4 $3.72
12/31/2021423,300 shares $1.71 million +5.4%N/A0.8 $4.05
12/15/2021401,700 shares $1.27 million +25.2%N/A0.8 $3.15
11/30/2021320,800 shares $1.75 million +4.8%N/A0.9 $5.44
11/15/2021306,200 shares $2.50 million -18.1%N/A0.4 $8.15
10/29/2021373,800 shares $4.68 million -9.8%N/A0.4 $12.52
10/15/2021414,600 shares $5.78 million +37.7%N/A0.5 $13.95
9/30/2021301,200 shares $3.26 million +78.0%N/A0.7 $10.82
9/15/2021169,200 shares $2.29 million +3.2%N/A0.4 $13.53
8/31/2021164,000 shares $3.15 million +98.6%N/A0.4 $19.20
8/13/202182,600 shares $1.68 million +32.2%N/A0.2 $20.30
7/30/202162,500 shares $1.39 million +79.1%N/A0.1 $22.17
7/15/202134,900 shares $731.16 thousand +160.5%N/A0.1 $20.95
6/30/202113,400 shares $0.00 -82.2%N/A0 $0.00

ONPH Short Interest - Frequently Asked Questions

What is Oncology Pharma's current short interest?

Short interest is the volume of Oncology Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 13,438 shares of ONPH short. 0.04% of Oncology Pharma's shares are currently sold short. Learn More on Oncology Pharma's current short interest.

What is a good short interest ratio for Oncology Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONPH shares currently have a short interest ratio of 0.2. Learn More on Oncology Pharma's short interest ratio.

What is a good short interest percentage for Oncology Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Oncology Pharma's floating shares are currently sold short.

How does Oncology Pharma's short interest compare to its competitors?

0.04% of Oncology Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "computer software" compare to Oncology Pharma: Nvni Group Limited (4.83%), Gaxos.ai Inc. (1.94%), Lianhe Sowell International Group Ltd (0.28%), Tenet Fintech Group Inc. (0.01%), T Stamp Inc. (3.90%), Bridgeline Digital, Inc. (0.09%), The Glimpse Group, Inc. (1.10%), VerifyMe, Inc. (1.61%), Datasea Inc. (1.61%), XIAO-I Corporation Unsponsored ADR (52.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Oncology Pharma stock?

Short selling ONPH is an investing strategy that aims to generate trading profit from Oncology Pharma as its price is falling. ONPH shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncology Pharma?

A short squeeze for Oncology Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONPH, which in turn drives the price of the stock up even further.

How often is Oncology Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONPH, twice per month. The most recent reporting period available is April, 15 2026.

What do ONPH's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like ONPH:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (OTCMKTS:ONPH) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel